Dear Editor, Vousden and colleagues present a timely clarion call for the involvement of pregnant women in clinical trials. The inequality faced by pregnant women when it comes to access to medications is known to bring them to harm as demonstrated by the MBRRACE-UK reports. It should also be noted however, that there is an urgent need for the development of therapeutics, including drugs, for the treatment of pregnancy specific conditions.